Seguir
Vibhavari Sail
Vibhavari Sail
Dirección de correo verificada de omrf.org
Título
Citado por
Citado por
Año
Repurposing the clinically efficacious antifungal agent itraconazole as an anticancer chemotherapeutic
JR Pace, AM DeBerardinis, V Sail, SK Tacheva-Grigorova, KA Chan, ...
Journal of medicinal chemistry 59 (8), 3635-3649, 2016
652016
Intestinal lineage commitment of embryonic stem cells
L Cao, JD Gibson, S Miyamoto, V Sail, R Verma, DW Rosenberg, ...
Differentiation 81 (1), 1-10, 2011
622011
Identification of small molecule translesion synthesis inhibitors that target the Rev1-CT/RIR protein− protein interaction
V Sail, AA Rizzo, N Chatterjee, RC Dash, Z Ozen, GC Walker, ...
ACS chemical biology 12 (7), 1903-1912, 2017
572017
Structure–activity relationships for vitamin D3-based aromatic A-ring analogues as Hedgehog pathway inhibitors
AM DeBerardinis, DJ Madden, U Banerjee, V Sail, DS Raccuia, ...
Journal of Medicinal Chemistry 57 (9), 3724-3736, 2014
332014
Notch pathway modulators as anticancer chemotherapeutics
V Sail, MK Hadden
Annual reports in medicinal chemistry 47, 267-280, 2012
192012
Identification of small molecule Hes1 modulators as potential anticancer chemotherapeutics
V Sail, MK Hadden
Chemical Biology & Drug Design 81 (3), 334-342, 2013
102013
Probing seco-steroid inhibition of the hedgehog signaling pathway
EN Thompson, V Sail, DS Raccuia, MK Hadden
Molecular and Cellular Biochemistry 450, 75-85, 2019
22019
AB-2100, a PSMA-inducible CA9-specific CAR T cell product for the treatment of ccRCC provides long-term tumor responses in preclinical mouse model
S Mohanty, J Chen, A Gomez, A Boroughs, I Scarfo, L Lim, K Dang, ...
Cancer Research 84 (6_Supplement), 38-38, 2024
2024
Characterization of AB-1015 logic-gated CAR induction (ON kinetics), receptor turnover (OFF kinetics), and logic gate sensitivity to ALPG/P and MSLN
X Tang, M Chew, R Sudhakar, H Yun, D Sakamoto, V Sail, A Fearon, ...
Cancer Research 84 (6_Supplement), 6319-6319, 2024
2024
Enhancing TCR T cell function in solid tumors through in vivo combinatorial screens and single-cell analysis
D Polyak, J Fuhriman, J Susanto, A Merrell, M Simon, C Oh, A Cordazo, ...
Cancer Research 84 (6_Supplement), 7042-7042, 2024
2024
Pooled CRISPR screening coupled with single-cell sequencing identifies modifiers of CAR T cell state in the context of chronic antigen stimulation
S Joshi, G Wozniak, J Gagnon, K Vucci, A Merrell, M Simon, C Oh, ...
Cancer Research 84 (6_Supplement), 7034-7034, 2024
2024
Development of AB-2100, an autologous integrated circuit T (ICT) cell therapy targeting CA9 intended for the treatment of ccRCC.
M Landon, I Scarfo, M Chew, R Sudhakah, M Nguyen, S Mohanty, J Chen, ...
Journal of Clinical Oncology 42 (4_suppl), 472-472, 2024
2024
301 Preclinical development of AB-2100, a PSMA neovasculature-inducible CA9 CAR resistant to FASL and TGFb mediated suppression for the treatment of ccRCC
I Scarfo, L Lim, K Dang, M Chew, R Sudhakah, M Nguyen, S Mohanty, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
A neovasculature-inducible CA9 CAR resistant to FASL and TGFb mediated suppression for the treatment of ccRCC
AC Boroughs, I Scarfo, N Attanasio, T Gardner, JB Smith, J McDevitt, ...
Cancer Research 83 (7_Supplement), 4088-4088, 2023
2023
Identification of small molecule translesion synthesis inhibitors that target Rev1 protein-protein interactions
M Hadden, V Sail, E Thompson, A Rizzo, D Korzhnev
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–15